cdmo.directory
← Compare landing

Ajinomoto Bio-Pharma Services vs TriLink BioTechnologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ajibio-pharma/trilinkbiotech

CategoryAjinomoto Bio-Pharma ServicesTriLink BioTechnologies
Listed sitecdmocdmo
SummaryAjinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service. The company offers a comprehensive portfolio of manufacturing and development…TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
Services
  • Process Development
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
Modalities
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Gene Therapy
  • Peptide
  • mRNA
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Belgium, Belgium, Belgium
  • United States, United States
  • Japan, Japan
  • India, India
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.